M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT03678441
This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
PRIMARY OBJECTIVES:
I. Evaluate feasibility of the electronic batteries, measured by the completion rate and time to completion of the batteries.
SECONDARY OBJECTIVES:
I. Comparison of the completion rate and time to completion between the written and electronic batteries.
II. Comparison of the scoring distribution between the screening tools.
EXPLORATORY OBJECTIVES:
I. Assess if a history of mental or cognitive illness or ongoing treatment with neuropsychiatric medications impact the ability to complete written and/or electronic neurocognitive screening.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen cognitive assessment within 2 months prior to surgery and within 2 months after surgery.
GROUP II: Patients receive the paper and pen cognitive assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Receive BrainCheck cognitive assessment
Other names: BrainCheck
Receive pen and paper cognitive assessment
Time frame: Up to 1 year
Will be calculated along with a 95% confidence interval (CI).
Time frame: Up to 1 year
Will be calculated along with a 95% CI.
Time frame: Up to 1 year
Will be calculated along with a 95% CI.
Time frame: Up to 1 year
Will be calculated along with a 95% CI.
Time frame: Up to 1 year
Will be calculated along with 95% CIs.
Time frame: Up to 1 year
Will be calculated along with 95% CIs.
Time frame: Up to 1 year
Will be calculated along with 95% CIs.
Time frame: Up to 1 year
Will be calculated along with 95% CIs.
M.D. Anderson Cancer Center
Other
A Feasibility Study of Electronic Neurocognitive Screening Tools in Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03214510
Digestive System Diseases, Liver and Intrahepatic Bile Duct Disorder
Houston, Texas, United States
View Trial DetailsNCT02156739
Adenocarcinoma, Carcinoma
Houston, Texas, United States
View Trial DetailsNCT05876182
Bile Duct Diseases, Biliary Tract Diseases
Monza, Monza E Brianza, Italy
View Trial DetailsNCT07228403
Digestive System Diseases, Gastrointestinal Diseases
Rochester, Minnesota, United States
View Trial Details